Clinical and economic impact of treated CMV infection in adult CMV-seropositive patients after allogeneic hematopoietic cell transplantation.

Regis Peffault de LatourPatrice ChevallierDidier BlaiseSarah AlamiLaurie Lévy-BachelotThierry AllavoineAbir TadmouriJosefin BlomkvistAlain DuhamelMicha SrourDavid BeauvaisIbrahim Yakoub-Agha

Published in: Journal of medical virology (2020)

In this large cohort of CMV-seropositive patients undergoing allo-HCT, treated CMV infection was significantly associated with an increased 1-year risk of overall mortality, with increased length of stay and with hospitalization cost. The burden of CMV disease in allo-HCT could be reduced in the future by appropriate prophylactic strategies.

Keyphrases

patients undergoing
newly diagnosed
end stage renal disease
ejection fraction
chronic kidney disease
stem cell transplantation
prognostic factors
risk factors
peritoneal dialysis
cardiovascular events
cardiovascular disease
low dose
cell cycle arrest